birth control and tirzepatide Oral Contraceptives Tirzepatide: Important Guidance Birth Control and Tirzepatide: Safety

Reduced Hunger : Semaglutides appetite-suppressing effects combined with HCGs hunger-curbing capabilities can help you stick to your dietary plan more easily

Clinical trials (STEP programme) have demonstrated significant weight loss, with participants losing an average of 12-15% of their initial body weight over 68 weeks when combined with lifestyle interventions

The MHRA approved the indication in July 2024 based on the SELECT trial, in which Wegovy 2.4 mg reduced heart attack, stroke, and cardiovascular death by 20% over an average of 33 months in adults with overweight or obesity and existing cardiovascular disease

A Smarter Approach to Appetite Support At the center of the formula is GLP-1 (glucagon-like peptide-1), a naturally occurring hormone released in the gut after eating